The rise in geriatric population, bioresorbable vascular scaffolds, developments in interventional cardiology devices have resulted in boosting the Interventional Cardiology Devices market. 

The global interventional cardiology devices market is forecast to reach USD 26.71 Billion by 2028, according to a new report by Reports and Data. Interventional cardiology can be defined as a branch of cardiology that focuses specifically on the treatment of structural heart diseases, based on catheters. It is contrary to noninvasive or preventive treatments such as lifestyle changes and most imaging techniques, wherein this method of treatment mainly deals with more invasive treatments, involving stenting and catheters. Previously open-heart surgery was considered as the only option for care users having narrowing aortic heart valve or at a high risk of aortic stenosis. The fact that this form of cardiovascular treatment is a non-surgical option has resulted in its growing popularity, which in turn is boosting the demand for interventional cardiology devices. Furthermore, growing geriatric population and developments in interventional cardiology devices are some of the factors further propelling the growth of the market.

Get a sample copy of the global Interventional Cardiology Devices market report @ https://www.reportsanddata.com/sample-enquiry-form/2361

Substantial revenue growth of the global pharma & healthcare market is driven by factors such as growing burden of chronic and acute diseases across the globe, rise in geriatric population, growing consumer awareness of health & wellness, and increasing need for more advanced and patient-centered healthcare services. Some of the other major factors contributing to market revenue growth are growing demand for advanced medications and therapeutics, growing availability of advanced point-of-care diagnostics, increasing research & development activities and clinical trials in the biotechnology and pharmaceutical industries, and rise in government and private investments in the healthcare sector. Rising cases of the novel coronavirus infection globally, rapid development of advanced COVID-19 diagnostics including the RT-PCR test kits, increased government investments in COVID-19 vaccine development, growing trends of telehealth and telemedicine, and increasing demand for remote patient monitoring solutions are factors further driving market revenue growth to a major extent.

Global Interventional Cardiology Devices Market Report: Regional Segmentation

  • North America
    • S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • K.
    • Italy
    • France
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • A.E.
    • South Africa
    • Rest of MEA

Further key findings from the report suggest

  • The Interventional Cardiology Devices market held a market share of USD 15.49 Billion in the year 2018 that is forecasted to grow at a rate of 7.1% during the forecast period.
  • In context to Product Type, the Stents segment generated the highest revenue of USD 8.52 Billion in the year 2018, with a growth rate of 7.4% during the forecast period. The extensive application of the cardiology devices in angioplasty procedures, wherein it is applied in more than 70% of these procedures, contributes to the revenue generated by this segment. A combination of stenting and angioplasty helps in enhancing the quality of life, particularly when performed after a heart attack, also contributes to its high acceptance and recommendation among care service providers.
  • In context to Application, the Coronary angioplasty segment can be seen to generate the highest revenue of USD 4.34 Billion in 2018, with a growth rate of 7.3% during the forecast period. The high incidence rate of coronary artery diseases and applicability of angioplasty and associated devices in the treatment of the condition contributes to the revenue generated by this segment.
  • In context to End-user, the Hospital segment is dominating that generated the highest revenue of USD 8.67 Billion in 2018, with a CAGR of 7.2% during the forecast period. The revenue generated by the segment is resultant of an increasing rate of hospitalization associated with cardiovascular diseases and elevated demand for interventional cardiology devices for providing treatment to these care users in hospitals.
  • In regards to the region, Asia Pacific is projected to witness the fastest growth rate of 8.1% during the forecast, which is expected to hold 0% of the market by 2027. The growth rate witnessed by the region is resultant of developing healthcare infrastructure and increasing incidence rate of cardiovascular diseases in this region.

 

Top Players in the Global Interventional Cardiology Devices Market:

Abbott, Terumo Medical Corporation, Medtronic Inc., Boston Scientific Corporation, B Braun Melsungen, Johnson & Johnson, Ivascular, C. R. Bard, Terumo Corporation and Biotronik.

Avail a Order on the report @ https://www.reportsanddata.com/report-pricing/2361

Frequently Asked Questions Answered in the Report:

  • What is the expected revenue growth rate of the global Interventional Cardiology Devices market over the forecast period?
  • What are the key factors driving the global market revenue growth?
  • What are the key outcomes of SWOT analysis and Porter’s Five Forces analysis of the market?
  • Which regional market is expected to lead in terms of revenue share over the forecast years?
  • Which are the leading manufacturers and suppliers in the global Interventional Cardiology Devices market?

Request a customized copy of the Interventional Cardiology Devices market report @ https://www.reportsanddata.com/request-customization-form/2361

Thank you for reading our report. Please connect with us to know more about the report and its customization feature. Our team will ensure the report is well suited to meet your requirements.

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: [email protected]